A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2002
11/21/2002	US20020172673 Method for down-regulating IgE
11/21/2002	US20020172660 For therapy of cancer, viral infections
11/21/2002	CA2447593A1 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447564A1 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	CA2447548A1 Complexes for transferring substances of interest into a cell
11/21/2002	CA2447518A1 Therapeutic use of rank antagonists
11/21/2002	CA2447513A1 Compositions and methods for treating tumors bearing hmfg and cea antigens
11/21/2002	CA2447287A1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	CA2447139A1 Specific binding proteins and uses thereof
11/21/2002	CA2447114A1 Human antipneumococcal antibodies from non-human animals
11/21/2002	CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	CA2447017A1 Moraxella(branhamella) catarrhalis antigens
11/21/2002	CA2446956A1 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer
11/21/2002	CA2446953A1 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002	CA2446859A1 Transgenic animal model of bone mass modulation
11/21/2002	CA2446821A1 Hbm variants that modulate bone mass and lipid levels
11/21/2002	CA2446806A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
11/21/2002	CA2446704A1 Method for preparing human immunoglobulin concentrates for therapeutic use
11/21/2002	CA2446589A1 Methods for treating cancer
11/21/2002	CA2446582A1 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	CA2446555A1 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002	CA2446108A1 Compositions for use in treating ige-associated disorders
11/21/2002	CA2446072A1 Treating epidermolysis bullosa with thymosin beta 4
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/21/2002	CA2443627A1 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002	CA2443160A1 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	CA2442144A1 A helper dependent adenoviral vector system and methods for using the same
11/20/2002	EP1258494A1 Multiprotein complexes from eukaryotes
11/20/2002	EP1258492A1 N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases
11/20/2002	EP1258255A1 Conjugates of an antibody to CD44 and a maytansinoid
11/20/2002	EP1257827A1 Diagnosis of breast cancer using bcmp-11 as marker
11/20/2002	EP1257822A1 Her-2 binding antagonists
11/20/2002	EP1257817A2 Antigenic fragments associated with stress-induced proteins and their use as vaccines
11/20/2002	EP1257657A2 Autoregulatory expression vector for gene therapy
11/20/2002	EP1257653A2 Phosphodiesterase type 7b
11/20/2002	EP1257650A1 Polymerase compositions and methods of use thereof
11/20/2002	EP1257648A1 Antagonistic selective binding agents of osteoprotegerin binding protein
11/20/2002	EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002	EP1257642A1 Partners of ptb1 domain of fe65, preparation and uses
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257584A2 Humanized antibodies that sequester amyloid beta peptide
11/20/2002	EP1257583A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257569A2 Cold-adapted equine influenza viruses
11/20/2002	EP1257565A1 Mucin-1 derived antigens and their use in immunotherapy
11/20/2002	EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002	EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002	EP1257297A2 Compositions and methods for treatment of angiogenesis in pathological lesions
11/20/2002	EP1257296A2 Caspase activated prodrugs therapy
11/20/2002	EP1257293A2 Immunomodulatory effective compositions, methods for the production thereof and their use
11/20/2002	EP1257292A1 Use of il-18 inhibitors
11/20/2002	EP1257291A1 Novel antibody with specificity for colon cancer
11/20/2002	EP1257289A1 Immunotherapy using interleukin 13 receptor subunit alpha 2
11/20/2002	EP1257287A1 Compositions and methods for the early diagnosis of ovarian cancer
11/20/2002	EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
11/20/2002	EP1257284A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
11/20/2002	EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002	EP0847280B1 Compositions and their uses against hyperacute rejection of xenografts and certain diseases
11/20/2002	EP0758394B1 Bifunctional protein, preparation and use
11/20/2002	EP0652772B1 Herpesvirus vaccines
11/20/2002	CN1380884A Novel recombinant antibodies, amino acid sequences of CDR thereof and genes encoding the same
11/20/2002	CN1380422A Method for defining molecule being involved in adhesion and vaccine containing immunogenic peptide identified by said method
11/20/2002	CN1380420A New-type adenovirus with tumor cell specific infection and transgenic expression capability
11/20/2002	CN1380414A Recombinant human II type collagen functional polypeptide C II 250-270 and its preparation method and application
11/20/2002	CN1380341A Single-stranded cyctic trispecific antibody
11/20/2002	CN1380340A 重组乙肝病毒免疫球蛋白 Recombinant hepatitis B virus immune globulin
11/20/2002	CN1380098A Anti-infection compound preparation and its preparation method
11/19/2002	US6482929 Antibodies to ARF-p19
11/19/2002	US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002	US6482924 Leptospira vaccine antigens for the prevention of Leptospirosis
11/19/2002	US6482807 LPS with reduced toxicity from genetically modified gram negative bacteria
11/19/2002	US6482804 Compositions and methods for delivery of genetic material
11/19/2002	US6482623 Lipid kinase
11/19/2002	US6482614 Stress proteins and uses therefor
11/19/2002	US6482612 Adipocyte-specific protein homologs
11/19/2002	US6482597 Compounds and methods for therapy and diagnosis of lung cancer
11/19/2002	US6482517 Coated particles, methods of making and using
11/19/2002	US6482416 Alteration of macrophage-induced t cell suppression or concentration by the selective elimination or increase of tryptophan by administering an enzyme inhibitor of indole-amino 2,3-deoxygenase; viricides; abortion; fertility;
11/19/2002	US6482415 Expression and refolding of truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi and its use in antibody based detection assays and vaccines
11/19/2002	US6482414 Cold-adapted equine influenza viruses
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	US6482407 Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same
11/19/2002	US6482404 Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor
11/19/2002	US6481360 Ultra fine fly ash and a system for collecting the same
11/19/2002	CA2312667C Novel cytokine
11/19/2002	CA2261579C Isolated peptides derived from mage-2
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2086101C Immune suppressive product from milk
11/16/2002	CA2382977A1 Plasmodium falciparum antigens and their vaccinal and diagnostic applications
11/15/2002	WO2001087347A1 Heterobifunctional cross-linking agent conjugate substituted by an immunomodulator and cell recognition unit
11/15/2002	CA2409255A1 Heterobifunctional cross-linking agent conjugate substituted by an immunomodulator and cell recognition unit
11/14/2002	WO2002091212A2 Modular personal device system
11/14/2002	WO2002090981A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090566A2 Recombinant tumor specific antibody and use thereof
11/14/2002	WO2002090558A1 Novel expression vectors and uses thereof
11/14/2002	WO2002090555A1 A method for transfection of rna using electrical pulses
11/14/2002	WO2002090542A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
11/14/2002	WO2002090530A2 Kinases and phosphatases

1 ... 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 ... 1823